Table 1.
Clinical and biochemical characteristics of volunteers at baseline and after 3 months of treatment. (n=12) Results are mean+/−SD.
| Parameter | Baseline | 3-month | P value |
|---|---|---|---|
| Age (years) | 43.67±7.8 | ||
| Gender: | |||
| Male N(%) | 10 (83) | ||
| Female N(%) | 2 (17) | ||
| Race: | |||
| White N(%) | 3 (25) | ||
| Hispanic N(%) | 6 (50) | ||
| African American N(%) | 3 (25) | ||
|
| |||
| Weight (kg) | 106.21±16.0 | 108.28±15.8 | 0.313 |
| HbA1C (%) | 11.21±2.1 | 6.07±0.4 | <0.0001 |
| Total Cholesterol (mg/dl) | 177.3±53.2 | 162.8±40.8 | 0.281 |
| Triglyceride (mg/dl) | 165.3±77.5 | 134.1±58.8 | 0.210 |
| AST (IU/l) | 31.2±18.7 | 17.4±4.6 | 0.031 |
| ALT (IU/l) | 44.7±32.3 | 20.2±6.8 | 0.015 |
|
| |||
| Dose of insulin (U/day) | 55.4±20.02 | ||
|
| |||
| Hepatic TG content (%) | 11.12±7.7 | 6.1±6.6 | <0.0001 |